Efficacy of Light Therapy in Treatment of Chronic Cluster Headache

Condition(s) studied

Investigational drug(s) / intervention(s)

use of Luminettes ® with active light emission: Spectrum of 400 \< X \< 750 nm assumed active

use of Luminettes ® with a light emission presumed to have no therapeutic effect: Modification of spectrum parameters for wavelengths covered, with light emission in a spectrum of 560 \< X \< 650 nm assumed to have no therapeutic effect

Study summary

Cluster headache is a primary headache. The chronic form of the disease is often difficult to treat. It is now considered a chronobiological disease. This chronobiological character is based on clinical, biological and radiological arguments.

This study focuses on the use of light therapy in cluster headache. Light therapy has already been used in the treatment of other chronobiological diseases, such as seasonal depression, but also recently in the therapy of other primary headaches (such as migraine). Its aim is to re-adjust chronobiological rhythms, and it therefore seems worth testing in the chronic form of cluster headache.

Light therapy is delivered to the patient using a consumer electronics device.The main objective is to evaluate the prophylactic efficacy of light therapy in patients with chronic cluster headache.

Eligibility

Primary outcome measure(s)

• The median weekly number of cluster headache attacks — At day 28
  The difference in the median weekly number of cluster headache attacks between the month prior to randomization and the month of the double-blind period, between the two arms.

Trial sites (2)

More Assistance Publique Hopitaux De Marseille trials in France

Other trials for the same condition